协同和冗余的信息动态受到阿尔茨海默病和认知障碍的调节
bioRxiv : the preprint server for biology
|February 27, 2026
概括
早期阿尔茨海默病 (AD) 的诊断很困难. 新的大脑信息分析显示,阿尔茨海默病患者的协同作用减少和冗余性增加,为早期检测和追踪认知衰退提供了潜在的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 信息理论 信息理论
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降.
- 早期和准确的阿尔茨海默病诊断仍然是一个重大的临床挑战.
- 信息理论方法为量化大脑动态和识别潜在生物标志物提供了新的方法.
研究的目的:
- 在阿尔茨海默病中调查综合信息分解 (ΦID) 措施的诊断灵敏度.
- 确定 ΦID 测量是否可以跟踪整个阿尔茨海默氏症病谱的认知变化.
- 探索大脑信息处理,认知和AD进展之间的关系.
主要方法:
- 应用综合信息分解 (ΦID) 到休息状态功能磁共振成像 (fMRI) 数据来自阿尔茨海默氏病神经成像计划 (ADNI).
- 在认知正常 (CN),轻度认知障碍 (MCI) 和AD群体的大脑区域的量化总协同和冗余.
- 使用蒙特利尔认知评估 (MoCA) 与认知表现相关的 ΦID 测量.
主要成果:
- 与认知正常 (CN) 个体相比,阿尔茨海默病 (AD) 患者的全球大脑协同作用显著减少,冗余性增加.
- 协同效应的减少和冗余的增加在执行模式和默认模式网络中尤为明显.
- 轻度认知障碍 (MCI) 显示了一个中间模式,表明了潜在的早期补偿机制.
- 在高和低认知表现者之间观察到类似的协同冗余转移,反映了CN到AD的过渡.
结论:
- 阿尔茨海默病的特点是有着独特的信息处理特征:减少了全球协同作用和增加了冗余性.
- 这些信息动态变化甚至可以在早期轻度认知障碍 (MCI) 阶段检测到.
- ΦID措施为早期诊断,分层和阿尔茨海默病监测提供了一个有希望的新方法.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.0K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.8K
相关概念视频
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Interference and Decay
523
Forgetting is a complex cognitive phenomenon influenced by several factors, among which interference and decay are particularly prominent. These processes explain why individuals often struggle to retrieve specific information from memory, leading to lapses in recall that can be observed in everyday situations.
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
523
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Cognitive Development During Adulthood
988
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
988
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
735
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
735
Role of Neurotransmitters in Memory
2.7K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.7K
